4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-23-006433
Chief Medical Officer sold 311,297 shares at $8.25 ($2,568,200)
- Chief Medical Officer acquired 311,297 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Agresta Samuel Chief Medical Officer | 2023-08-16 | Option exercise | +311,297 | $3.72 | $1,158,025 | 311,297 | D |
| Agresta Samuel Chief Medical Officer | 2023-08-16 | Sale | −311,297 | $8.25 | $2,568,200 | 0 | D |
| Derivatives | |||||||
| Agresta Samuel Chief Medical Officer | 2023-08-16 | Option exercise · Stock Option (right to buy) | −311,297 | 0 | D | ||
| Open-market sales · 311,297 sh · avg $8.25 · $2,568,200 | |||||||
Loading xslF345X05/primarydocument.xml…